Insiders Avalo Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
10.85 ^USD	-5.57%		-24.44%	+19.23%

Apr. 17	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 16	Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35	MT

Avalo Therapeutics, Inc. Announces Board Appointments	Mar. 27	CI
Avalo Therapeutics Announces Board Changes	22-08-11	CI
Mind Medicine Names Schond Greenway as CFO	22-05-23	MT
Avalo Therapeutics, Inc. Announces Executive and Board Changes	22-02-18	CI
Avalo Therapeutics Promotes Neil to Chief Executive, Sullivan to Finance Chief	22-02-17	MT
Avalo Therapeutics, Inc. Announces Chief Executive Officer Changes	22-02-17	CI
Avalo Therapeutics, Inc. Announces Resignation of H. Jeffrey Wilkins as Chief Medical Officer	22-02-08	CI
Avalo Therapeutics Appoints Chief Commercial Officer	22-01-11	MT
Avalo Therapeutics, Inc. Appoints Stephen Smolinski as Chief Commercial Officer	22-01-10	CI
Avalo Therapeutics, Inc. Announces Changes to Its Board	21-12-15	CI
Avalo Therapeutics, Inc. Announces Executive Changes	21-12-06	CI
Avalo Therapeutics, Inc. Appoints Keith Maher to the Board	21-10-18	CI
Cerecor Inc. has Changed its Name to Avalo Therapeutics, Inc	21-08-26	CI
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Cerecor Stock	21-08-18	MT
Insider Trends: Insider Buying Continued with Purchase of Cerecor Stock	21-08-06	MT
Cerecor Inc. Announces Board Changes	21-06-21	CI
Insider Trends: Insider Buying Continued with Purchase of Cerecor Stock	21-05-18	MT
Cerecor Inc. Appoints Schond L. Greenway as Chief Financial Officer	21-03-01	CI
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Cerecor Stock	20-11-25	MT
Cerecor Inc. Appoints Gilla Kaplan, to Its Board of Directors	20-10-12	CI

No results for this search